Published 1 year ago • loading... • Updated 1 year ago

Molnupiravir: COVID drug linked to mutations that could 'spread the illness', scientists say

A study has found that the antiviral drug molnupiravir can cause mutations in the COVID-19 virus, potentially leading to further infection and genetic diversity in the surviving viral population.
These mutations were more likely in older age groups, which aligns with the use of antiviral treatment in higher-risk individuals.
The findings of the study have raised questions about the overall benefits and risks of molnupiravir and similar drugs, urging regulators to consider the possibility of persistent antiviral-induced mutations when developing new treatments.

Insights by Ground AI

Does this summary seem wrong?

29 Articles

All

Left

Center

Right

South China Morning Post

Anti-Covid drug may have led to virus mutations: study

Pharmaceutical giant Merck’s antiviral pill molnupiravir was one of the earliest treatments rolled out during the pandemic to prevent Covid becoming more severe in vulnerable people.

1 year ago·Hong Kong

Read Full Article

News Medical

Research uncovers a link between antiviral drug for COVID-19 and SARS-CoV-2 mutations

Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town and UKHSA have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.

1 year ago·United States

Read Full Article

SBS News

How the use of this anti-COVID drug may have led to mutations in the virus

Molnupiravir was one of the earliest treatments rolled out during the pandemic, and works mainly by creating mutations in the virus with the goal of weakening and killing it.

1 year ago·Sydney, Australia

Read Full Article

The Gateway Pundit

REVEALED: Popular COVID Drug Manufactured by Merck is Causing "Unintended" Virus Mutations, Potentially Fueling COVID's Spread

An international team of researchers has determined that a popular drug manufactured by Merck to treat COVID-19 is driving what is being described as “unintended” mutations in the virus and potentially fueling the virus’s spread The Express reported Monday that these researchers studied a whopping 15 million COVID-19 sequences to determine how it has mutated over time.

1 year ago·United States

Read Full Article

The Hill

Potential link found between Merck antiviral and mutated COVID strains

Molnupiravir, known commercially as Lagevrio, is one of two COVID-19 antivirals authorized for treating coronavirus infections along with Paxlovid from Pfizer.

1 year ago·Washington, United States

Read Full Article